Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03223935
Other study ID # HS20792 (B2017:059)
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 11, 2017
Est. completion date April 4, 2018

Study information

Verified date April 2021
Source University of Manitoba
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

An investigation on the effects of roasted pulse snacks on post-prandial glycemic and satiety response in healthy young adults.


Description:

An acute, randomized, controlled cross-over trial examining the post-prandial glycemic and satiety response to six snacks will be conducted. The study treatments are: 1) roasted corn nuts, 2) roasted chickpeas, 3) roasted yellow peas, 4) roasted pinto beans 5) roasted soybeans, and 6) roasted almonds. They will be matched for calorie content and provided in 200 kcal servings.


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date April 4, 2018
Est. primary completion date April 4, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - BMI: =18.5 and =29.9 kg/m2 - Fasting serum glucose: =5.5 mmol/L Exclusion Criteria: - Fasting serum glucose > 5.5 mmol/L - Smoking - Thyroid problems - Previous history of cardiovascular disease, diabetes, liver or kidney disease, inflammatory bowel disease, celiac disease, short bowel syndrome, any malabsorptive syndrome, pancreatitis, gallbladder or biliary disease - Presence of a gastrointestinal disorder or surgeries within the past year - Consuming prescription or non-prescription drug, herbal or nutritional supplements known to affect blood glucose or that could affect the outcome of the study as per investigator's judgment - Known to be pregnant or lactating - Known intolerance, sensitivity or allergy to any ingredients in the study products. - Extreme dietary habits (i.e. Atkins diet, very high protein diets, etc.) - Uncontrolled hypertension (systolic blood pressure =140 mm Hg or diastolic blood pressure =90 mm Hg) - Weight gain or loss of at least 10lbs in previous three months - Excessive alcohol intake - Restrained Eaters (identified by Eating Habits Questionnaire)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Corn nuts
Roasted corn nut snack
Chickpeas
Roasted chickpea snack
Yellow peas
Roasted yellow pea snack
Pinto beans
Roasted pinto bean snack
Soybeans
Roasted soybean snack
Almonds
Roasted almond snack

Locations

Country Name City State
Canada Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba Winnipeg Manitoba

Sponsors (3)

Lead Sponsor Collaborator
University of Manitoba Pulse Canada, Saskatchewan Pulse Growers

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Food intake Ab libitum meal At 60 min
Secondary Subjective appetite Measured by VAS questionnaire at 12 time points used to calculate area under the curve 0-200 min
Secondary Blood glucose concentrations Measured in blood using a glucometer at 12 time points and used to calculate area under the curve 0-200 min
Secondary Physical comfort Measured by VAS questionnaire at 12 time points to calculate area under the curve 0-200 min
Secondary Energy and fatigue Measured by VAS questionnaire at 12 time points to calculate area under the curve 0-200 min
Secondary Palatability of meal Measured by VAS questionnaire At 60 min
Secondary Palatability of treatment Measured by VAS questionnaire At 5 min
See also
  Status Clinical Trial Phase
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Terminated NCT03299881 - Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss N/A
Completed NCT02805478 - Fat-Associated Cardiovascular Organ Dysfunction
Active, not recruiting NCT02558920 - Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
Completed NCT03759743 - Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject N/A
Completed NCT03610958 - Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss. N/A
Completed NCT03678766 - CHARGE: Controlling Hunger and ReGulating Eating N/A
Completed NCT04430465 - Effects of Wholegrains on Children's Health (KORN) N/A
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT05376865 - Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers N/A
Completed NCT03625427 - Effect of Palmitoleic Acid on C-reactive Protein N/A
Active, not recruiting NCT03435445 - Online Platform for Healthy Weight Loss (POEmaS) N/A
Enrolling by invitation NCT05576116 - Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics N/A
Recruiting NCT05249465 - Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention N/A
Active, not recruiting NCT06023095 - A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities Phase 1
Completed NCT03648892 - Brain Dopamine Function in Human Obesity Early Phase 1
Not yet recruiting NCT05751993 - Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions N/A
Recruiting NCT02887950 - Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause N/A
Completed NCT02829229 - Community-based Obesity Treatment in African American Women After Childbirth N/A
Terminated NCT02796144 - MEtformin and Lorcaserin for WeighT Loss in Schizophrenia Phase 4